Pete A. Meyers

CIK 1590862 · Chief Financial Officer · last filed 2020-01-27

Pete A. Meyers is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider had shares withheld for taxes covering $95.8K of EGRX on Jan 27, 2020. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

12

Lifetime Open-Market Net

$1.09M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Chief Financial Officer 43,615 $2.14 $93.3K $44.4K 7 2020-01-27
TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted CFO & Treasurer 153,891 $1.05M 5 2015-03-31

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-01-27 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Tax (F) −1,653 -$95.8K EDGAR
2020-01-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed +18,868 -$36.3K EDGAR
2019-01-25 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed +18,700 -$24.8K EDGAR
2018-01-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) +7,000 $0 EDGAR
2017-08-16 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Buy (P) +350 $19.4K EDGAR
2017-06-12 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Buy (P) +350 $25.0K EDGAR
2017-05-15 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) $0 EDGAR
2015-03-31 TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted Buy (P) +5,000 $21.8K EDGAR
2015-01-30 TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted Grant (A) $0 EDGAR
2014-12-08 TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted Buy (P) +1,034 $5.1K EDGAR
Showing 110 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.